Sangeeta N. Bhatia, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 915 shares at $346.69 ($319K) on 2023-05-02, disclosed to the SEC on 2023-05-03.
Scheduled sale ($319k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $345.93 | 62 | $21K | 6.7% |
| 2 | $346.69 | 172 | $60K | 18.7% |
| 3 | $346.69 | 172 | $60K | 18.7% |
| 4 | $348.16 | 120 | $42K | 13.1% |
| 5 | $349.82 | 163 | $57K | 17.9% |
| 6 | $349.82 | 163 |
| $57K |
| 17.9% |
| 7 | $351.20 | 63 | $22K | 6.9% |
| Total | $348.26 avg | 915 | $319K | 100% |
| Filing → |
| VRTX | SELL | 2025-08-29 | $206K | — | Filing → |
| VRTX | SELL | 2025-05-05 | $202K | — | Filing → |
| VRTX | SELL | 2024-09-04 | $323K | — | Filing → |